Novartis Investigative Site

Ogden, Utah 84403

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic, Non-Hodgkin's Lymphoma

Studies at this site

• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early
• Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) — Completed